Annelies Van Rie gewoon hoogleraar

Publicaties Annelies Van Rie

Application of advanced epidemiological methods to improve the study of genomic guided treatment of drugresistant tuberculosis

Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,iv, 157 p.
Auteur(s)

Evaluation of DNA extraction methods from clinical Mycobacterium tuberculosis primary liquid culture for whole-genome sequencing

Bron
BMC genomics - ISSN 1471-2164-27:1 (2026) p.
Auteur(s)
    Emilyn Costa Conceicao, Mishka Haffejee, Felicia Wells, Brendon Mann, Tim Heupink, Astrid Paulse, Jennifer Williams, Anzaan Dippenaar, Yonas Ghebrekristos, Megan Burger, Vincent Rennie, Miguel de Diego Fuertes, Ilham Al-Talib, Nabila Ismail, Melanie Grobbelaar, Elizabeth Maria Streicher, Tulio de Oliveira, Gian van der Spuy, Annelies Van Rie, Robin Warren

Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis : a qualitative study

Bron
PLoS ONE - ISSN 1932-6203-21:6 (2026) p.
Auteur(s)
    Pham Hien Trang Tu, Antonio Barrenechea-Pulache, Katinka De Wet, Boitumelo Fanampe, Salome Charalambous, Annelies Van Rie

Convolutional neural networks quantify antibiotic resistance in Mycobacterium tuberculosis with diagnostic grade accuracy and predict treatment response

Bron
Nature communications - ISSN 2041-1723-17:1 (2026) p.
Auteur(s)
    Sanjana G. Kulkarni, Anna G. Green, Brendon C. Mann, Samantha Malatesta, Suchitra Kulkarni-Goodwin, Nina Cesare, Shandukani Mulaudzi, Noorjahn Rawoot, Keertan Dheda, Shaheed Vally Omar, Hafid Soualhine, Nazir Ismail, Barun Mathema, Neel Gandhi, Helen McIlleron, Satoshi Mitarai, Kyungjong Kim, Helen Cox, Stuart Meier, Elizabeth Streicher, Sacha Laurent, Timothy Rodwell, Carl-Michael Nathanson, Barry Kreiswirth, Elise DeVos, Daniela Cirillo, Vincent E. Escuyer, Elena Martinez, Vitali Sintchenko, Anzaan Dippenaar, Tim Heupink, Annelies Van Rie, James C.M. Brust, Robin M. Warren, Karen R. Jacobson, Maha R. Farhat

Whole genome sequencing precision medicine strategyto shorten treatment for rifampicin-resistant tuberculosis (SMARTT) : a pragmatic, randomised, single-blind phase 4 trial

Bron
The lancet respiratory medicine - ISSN 2213-2600-14:6 (2026) p. 521-532
Auteur(s)